Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn

Index by author

March 01, 2004; Volume 56,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

B

  1. Brink, Charles

    1. You have access
      International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4

C

  1. Catania, Anna

    1. You have access
      Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation
      Anna Catania, Stefano Gatti, Gualtiero Colombo and James M. Lipton
      Pharmacological Reviews March 2004, 56 (1) 1-29; DOI: https://doi.org/10.1124/pr.56.1.1
  2. Colombo, Gualtiero

    1. You have access
      Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation
      Anna Catania, Stefano Gatti, Gualtiero Colombo and James M. Lipton
      Pharmacological Reviews March 2004, 56 (1) 1-29; DOI: https://doi.org/10.1124/pr.56.1.1
  3. Commandeur, Jan N. M.

    1. You have access
      Enzyme-Catalyzed Activation of Anticancer Prodrugs
      Martijn Rooseboom, Jan N. M. Commandeur and Nico P. E. Vermeulen
      Pharmacological Reviews March 2004, 56 (1) 53-102; DOI: https://doi.org/10.1124/pr.56.1.3
  4. Costa, Lucio G.

    1. You have access
      Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects
      Lucio G. Costa, Luca Steardo and Vincenzo Cuomo
      Pharmacological Reviews March 2004, 56 (1) 103-147; DOI: https://doi.org/10.1124/pr.56.1.5
  5. Cuomo, Vincenzo

    1. You have access
      Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects
      Lucio G. Costa, Luca Steardo and Vincenzo Cuomo
      Pharmacological Reviews March 2004, 56 (1) 103-147; DOI: https://doi.org/10.1124/pr.56.1.5

D

  1. Dahlén, Sven-Erik

    1. You have access
      International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4
  2. Drazen, Jeffrey

    1. You have access
      International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4

E

  1. Evans, Jilly F.

    1. You have access
      International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4

G

  1. Gatti, Stefano

    1. You have access
      Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation
      Anna Catania, Stefano Gatti, Gualtiero Colombo and James M. Lipton
      Pharmacological Reviews March 2004, 56 (1) 1-29; DOI: https://doi.org/10.1124/pr.56.1.1

H

  1. Hay, Douglas W. P.

    1. You have access
      International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4

I

  1. Insel, Paul A.

    1. You have access
      Autonomic Nervous System Pharmacogenomics: A Progress Report
      Shelli L. Kirstein and Paul A. Insel
      Pharmacological Reviews March 2004, 56 (1) 31-52; DOI: https://doi.org/10.1124/pr.56.1.2

K

  1. Kirstein, Shelli L.

    1. You have access
      Autonomic Nervous System Pharmacogenomics: A Progress Report
      Shelli L. Kirstein and Paul A. Insel
      Pharmacological Reviews March 2004, 56 (1) 31-52; DOI: https://doi.org/10.1124/pr.56.1.2

L

  1. Lipton, James M.

    1. You have access
      Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation
      Anna Catania, Stefano Gatti, Gualtiero Colombo and James M. Lipton
      Pharmacological Reviews March 2004, 56 (1) 1-29; DOI: https://doi.org/10.1124/pr.56.1.1

R

  1. Rooseboom, Martijn

    1. You have access
      Enzyme-Catalyzed Activation of Anticancer Prodrugs
      Martijn Rooseboom, Jan N. M. Commandeur and Nico P. E. Vermeulen
      Pharmacological Reviews March 2004, 56 (1) 53-102; DOI: https://doi.org/10.1124/pr.56.1.3
  2. Rovati, G. Enrico

    1. You have access
      International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4

S

  1. Serhan, Charles N.

    1. You have access
      International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4
  2. Shimizu, Takao

    1. You have access
      International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4
  3. Steardo, Luca

    1. You have access
      Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects
      Lucio G. Costa, Luca Steardo and Vincenzo Cuomo
      Pharmacological Reviews March 2004, 56 (1) 103-147; DOI: https://doi.org/10.1124/pr.56.1.5

V

  1. Vermeulen, Nico P. E.

    1. You have access
      Enzyme-Catalyzed Activation of Anticancer Prodrugs
      Martijn Rooseboom, Jan N. M. Commandeur and Nico P. E. Vermeulen
      Pharmacological Reviews March 2004, 56 (1) 53-102; DOI: https://doi.org/10.1124/pr.56.1.3

Y

  1. Yokomizo, Takehiko

    1. You have access
      International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4
Back to top
PreviousNext

In this issue

Pharmacological Reviews: 56 (1)
Pharmacological Reviews
Vol. 56, Issue 1
1 Mar 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Nitric oxide: physiology, pathophysiology, and pharmacology.
  • The Glutamate Receptor Ion Channels
  • Receptors for Purines and Pyrimidines
  • Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling
  • Glutamate Receptor Ion Channels: Structure, Regulation, and Function
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics